Intravenous immunoglobulin in oncology nursing practice.
Intravenous immunoglobulin (IVIG) is a concentrated form of IgG, also known as gamma globulin, that is derived from the pooled serum of a large number of donors. IVIG contains many types of antibacterial and antiviral antibodies. While its use in certain clinical conditions (e.g., severe combined immunodeficiency) is well-established, other indications still are under investigation. Along with nursing implications for use in inpatient and outpatient settings, the role of IVIG in treating immune thrombocytopenic purpura, chronic lymphocytic leukemia, treatment-induced neutropenia and thrombocytopenia, bone marrow transplantation, and AIDS will be discussed.
Timmerman
P R
PR
Good Samaritan Hospital, Downers Grove, IL.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000917:Antibody Formation; D016026:Bone Marrow Transplantation; D002985:Clinical Protocols / Q000592:standards; D016527:Drug Costs; D004342:Drug Hypersensitivity / Q000453:epidemiology; D004348:Drug Labeling / Q000592:standards; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D009859:Oncology Nursing / Q000379:methods*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy; D014944:World Health Organization
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous